Piramal Pharma surged 14.67% to Rs 248.50 after the pharmaceutical company’s consolidated net profit zoomed 350% to Rs 22.59 crore in Q2 FY25 as against Rs 5.02 crore posted in Q2 FY24.
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
